Berthe M P Aleman

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi request reprint Involved-field radiotherapy for advanced Hodgkin's lymphoma
    Berthe M P Aleman
    Netherlands Cancer Institute, Amsterdam, The Netherlands
    N Engl J Med 348:2396-406. 2003
  2. ncbi request reprint Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 63:1184-90. 2005
  3. doi request reprint Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:27-34. 2010
  4. ncbi request reprint Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam
    Int J Radiat Oncol Biol Phys 67:19-30. 2007
  5. ncbi request reprint Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Hematol Oncol Clin North Am 21:961-75. 2007
  6. doi request reprint Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy
    Alexandra W van den Belt-Dusebout
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 75:1420-9. 2009
  7. doi request reprint Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma
    Marie L De Bruin
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 101:928-37. 2009
  8. ncbi request reprint Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer
    Alexandra W van den Belt-Dusebout
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:4370-8. 2007
  9. doi request reprint Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes
    Marie L De Bruin
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 27:4239-46. 2009
  10. ncbi request reprint Treatment-related risk factors for premature menopause following Hodgkin lymphoma
    Marie L De Bruin
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam
    Blood 111:101-8. 2008

Collaborators

Detail Information

Publications33

  1. ncbi request reprint Involved-field radiotherapy for advanced Hodgkin's lymphoma
    Berthe M P Aleman
    Netherlands Cancer Institute, Amsterdam, The Netherlands
    N Engl J Med 348:2396-406. 2003
    ..The use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial...
  2. ncbi request reprint Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 63:1184-90. 2005
    ....
  3. doi request reprint Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:27-34. 2010
    ..In patients with gastric DLBCL conservative treatment with anthracycline-based chemotherapy alone or in combination with involved-field radiotherapy has become the therapy of choice...
  4. ncbi request reprint Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam
    Int J Radiat Oncol Biol Phys 67:19-30. 2007
    ..The purpose of this study was to describe the role of radiotherapy in patients with advanced HL who were in partial remission (PR) after chemotherapy...
  5. ncbi request reprint Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Hematol Oncol Clin North Am 21:961-75. 2007
    ..Because treatment always has side effects to some extent, awareness of possible late effects after treatment remains important for patients and treating physicians...
  6. doi request reprint Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy
    Alexandra W van den Belt-Dusebout
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 75:1420-9. 2009
    ..To evaluate the roles of radiation dose, chemotherapy, and other factors in the etiology of stomach cancer in long-term survivors of testicular cancer or Hodgkin lymphoma...
  7. doi request reprint Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma
    Marie L De Bruin
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 101:928-37. 2009
    ..We quantified the long-term risk of cerebrovascular disease associated with the use of radiotherapy and chemotherapy in survivors of Hodgkin lymphoma and explored potential pathogenic mechanisms...
  8. ncbi request reprint Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer
    Alexandra W van den Belt-Dusebout
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:4370-8. 2007
    ..To compare radiotherapy and chemotherapy effects on long-term risks of second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs) in testicular cancer (TC) survivors...
  9. doi request reprint Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes
    Marie L De Bruin
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 27:4239-46. 2009
    ..We assessed the long-term risk of breast cancer (BC) after treatment for Hodgkin's lymphoma (HL). We focused on the volume of breast tissue exposed to radiation and the influence of gonadotoxic chemotherapy (CT)...
  10. ncbi request reprint Treatment-related risk factors for premature menopause following Hodgkin lymphoma
    Marie L De Bruin
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam
    Blood 111:101-8. 2008
    ..As long as alkylating agents will be used for curing HL, premature menopause will remain a frequent adverse treatment effect, with various clinical implications...
  11. ncbi request reprint Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials
    Evert M Noordijk
    Department of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
    J Clin Oncol 24:3128-35. 2006
    ..The aim of this study was to reduce this toxicity using a combination of low-intensity chemotherapy and involved-field radiotherapy (IF-RT) without jeopardizing disease control...
  12. doi request reprint Chemoradiation for esophageal cancer: institutional experience with three different regimens
    Ewout F W Courrech Staal
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Am J Clin Oncol 34:343-9. 2011
    ..The aim of this study was to retrospectively evaluate toxicity and efficacy of 3 chemoradiation regimens...
  13. doi request reprint Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer
    Maartje J Hooning
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 26:5561-8. 2008
    ..Few studies have examined whether modern radiotherapy and chemotherapy affect the risk of contralateral breast cancer (CBC), and results are inconclusive...
  14. ncbi request reprint Long-term risk of cardiovascular disease in 10-year survivors of breast cancer
    Maartje J Hooning
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Natl Cancer Inst 99:365-75. 2007
    ..Few data on long-term cardiovascular disease risk according to specific radiation fields are available, and interaction with known cardiovascular risk factors has not been examined...
  15. ncbi request reprint Decreased risk of stroke among 10-year survivors of breast cancer
    Maartje J Hooning
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:5388-94. 2006
    ..To assess treatment-specific risk of cerebrovascular events in early breast cancer (BC) patients, accounting for cerebrovascular risk factors...
  16. doi request reprint Malignant mesothelioma after radiation treatment for Hodgkin lymphoma
    Marie L De Bruin
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam
    Blood 113:3679-81. 2009
    ..The evidence for radiotherapy as cause for mesothelioma independent of exposure to asbestos is expanding, and the diagnosis of mesothelioma should be kept in mind whenever related symptoms arise in patients who had previous irradiation...
  17. ncbi request reprint Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study
    Maartje J Hooning
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 64:1081-91. 2006
    ..To assess long-term cause-specific mortality in breast cancer patients...
  18. ncbi request reprint [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma]
    A W Sandra van den Belt-Dusebout
    Het Nederlands Kanker Instituut Antoni van Leeuwenhoek Ziekenhuis, afd Epidemiologie, Amsterdam, The Netherlands
    Ned Tijdschr Geneeskd 154:A2229. 2010
    ..Because of the relatively high risks of late treatment complications, recommendations for follow-up for survivors of testicular cancer and Hodgkin lymphoma are necessary...
  19. ncbi request reprint Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer
    Alexandra W van den Belt-Dusebout
    Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:467-75. 2006
    ..To evaluate the long-term risk of cardiovascular disease (CVD) in survivors of testicular cancer (TC)...
  20. ncbi request reprint Long-term cause-specific mortality of patients treated for Hodgkin's disease
    Berthe M P Aleman
    Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 21:3431-9. 2003
    ..To assess long-term cause-specific mortality of young Hodgkin's disease (HD) patients...
  21. ncbi request reprint Late cardiotoxicity after treatment for Hodgkin lymphoma
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Blood 109:1878-86. 2007
    ..Anthracyclines further increase the elevated risks of CHF and valvular disorders from mediastinal radiotherapy...
  22. doi request reprint Long-term results of stomach-conserving therapy in gastric MALT lymphoma
    Conny Vrieling
    Department of Radiation Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands
    Radiother Oncol 87:405-11. 2008
    ..To evaluate long-term results of stomach-conserving therapy and to assess the value of histological probable minimal residual disease (pMRD) in predicting outcome in patients with gastric MALT lymphoma...
  23. doi request reprint Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment
    Jan Paul de Boer
    Department of Medical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Leuk Lymphoma 52:2262-9. 2011
    ..In addition an increase in density of FOXP3 + cells (i.e. Tregs) was seen (p = 0.047). These alterations in different T-cell subsets were not observed in gastric biopsy samples of patients treated with HP-eradication only...
  24. doi request reprint Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma
    Rick L M Haas
    Department of Radiotherapy, The Netherlands Cancer Institute Amsterdam, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 74:1199-202. 2009
    ..Considerable discussion is ongoing on the treatment of primary and relapsed disease...
  25. doi request reprint Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer
    Florentine S M Hilbers
    Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands
    Radiother Oncol 102:115-21. 2012
    ..We examined the effects of two polymorphisms, TGFβ1 29C>T and PAI-1 5G>4G, on CVD incidence...
  26. ncbi request reprint Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute and Antoni van Leeuwenhoeck Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 11:375-9. 2004
    ..This study evaluates the outcome of such recurrences after initial treatment by cytoreduction and HIPEC...
  27. ncbi request reprint Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
    Flora E van Leeuwen
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Natl Cancer Inst 95:971-80. 2003
    ..Female survivors of Hodgkin's disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not well known...
  28. doi request reprint Outcome of low-volume surgery for esophageal cancer in a high-volume referral center
    Ewout F W Courrech Staal
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 16:3219-26. 2009
    ..The objective of our study was to evaluate the results of esophageal cancer surgery in our institute and to compare these results with published data from high-surgical-volume institutions...
  29. ncbi request reprint Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma
    Elizabeth C Moser
    European Organisation for Research and Treatment of Cancer EORTC Data Center, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 66:1168-77. 2006
    ..We evaluated the impact of radiotherapy on outcome in PR patients treated in four successive European Organization for Research and Treatment of Cancer trials for aggressive NHL...
  30. ncbi request reprint Re: Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
    Berthe M P Aleman
    J Natl Cancer Inst 96:235-6; author reply 236-7. 2004
  31. ncbi request reprint Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume
    Jacques H Borger
    Maastricht Radiation Oncology Clinic, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 69:1131-8. 2007
    ..To assess the risk of cardiovascular disease (CVD) after postlumpectomy irradiation restricted to tangential fields...
  32. ncbi request reprint Radiotherapy in advanced-stage Hodgkin's lymphoma
    John M M Raemaekers
    J Clin Oncol 23:245-6; author reply 246. 2005
  33. ncbi request reprint Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
    Marjolein Y V Homs
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre Rotterdam, Rotterdam, Netherlands
    Lancet 364:1497-504. 2004
    ..We undertook a randomised trial to compare the outcomes of brachytherapy and stent placement in patients with oesophageal cancer...